Zobrazeno 1 - 10 of 27 pro vyhledávání: '"Mirjam, de Weijert"'
1
Akademický článek
Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma
Autor: Kazuhiro Nagao, Nachi Shinohara, Frank Smit, Mirjam de Weijert, Sander Jannink, Yuji Owada, Peter Mulders, Egbert Oosterwijk, Hideyasu Matsuyama
Publikováno v: BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background To identify potential therapeutic target in clear cell renal cell carcinoma (ccRCC), we performed a transcriptome analysis. Our analysis showed that fatty acid binding protein 7 (FABP7) has the highest mean differential overexpres
Externí odkaz: https://doaj.org/article/6a504b49891e44eb87e2b615169d35aa
Zobrazit plný text záznamu
5
Data from Targeted Dual-Modality Imaging in Renal Cell Carcinoma: An Ex Vivo Kidney Perfusion Study
Autor: Mark Rijpkema, Peter F.A. Mulders, Hans F. Langenhuijsen, Egbert Oosterwijk, Desirée L. Bos, Mirjam de Weijert, Otto C. Boerman, Marlène C.H. Hekman
Purpose: Antibodies labeled with both a near-infrared fluorescent dye and a radionuclide can be used for tumor-targeted intraoperative dual-modality imaging. Girentuximab is a chimeric monoclonal antibody against carbonic anhydrase IX (CAIX), an anti
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b57818152287c6e087c1efd68bf48b6
https://doi.org/10.1158/1078-0432.c.6525102.v1
Zobrazit plný text záznamu
6
Akademický článek
Neoadjuvant Sorafenib Treatment of Clear Cell Renal Cell Carcinoma and Release of Circulating Tumor Fragments
Autor: Gursah Kats-Ugurlu, Egbert Oosterwijk, Stijn Muselaers, Jeannette Oosterwijk-Wakka, Christina Hulsbergen-van de Kaa, Mirjam de Weijert, Han van Krieken, Ingrid Desar, Carla van Herpen, Cathy Maass, Rob de Waal, Peter Mulders, William Leenders
Publikováno v: Neoplasia: An International Journal for Oncology Research, Vol 16, Iss 3, Pp 221-228 (2014)
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is characterized by high constitutive vascular endothelial growth factor A (VEGF-A) production that induces a specific vascular phenotype. We previously reported that this phenotype may allow sheddi
Externí odkaz: https://doaj.org/article/fcd2d45b6c344205991842eae2eabfae
Zobrazit plný text záznamu
7
Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma
Autor: Nachi Shinohara, Frank Smit, Hideyasu Matsuyama, Kazuhiro Nagao, Yuji Owada, Peter F.A. Mulders, Egbert Oosterwijk, S.A. Jannink, Mirjam de Weijert
Publikováno v: BMC Cancer, 18
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Background To identify potential therapeutic target in clear cell renal cell carcinoma (ccRCC), we performed a transcriptome analysis. Our analysis showed that fatty acid binding protein 7 (FABP7) has the highest mean differential overexpression in c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a8cc7a6f70675fe60f9d552942a5ae1
https://hdl.handle.net/2066/198294
Zobrazit plný text záznamu
8
Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermia
Autor: Rianne J.M. Lammers, Diederik M. Somford, Harm C. Arentsen, J. Alfred Witjes, Antoine G. van der Heijden, J. Falke, Jan C.M. Hendriks, Mirjam de Weijert, Tom J.H. Arends, Egbert Oosterwijk
Publikováno v: World Journal of Urology, 33, 1411-7
World Journal of Urology, 33, 10, pp. 1411-7
Item does not contain fulltext OBJECTIVES: To explore whether urinary cytokine and chemokine (CK) levels differed between cold mitomycin-C (cold-MMC)-treated patients and chemohyperthermia (C-HT)-treated patients, to shed light on the possible molecu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9b29d26ba68b0b263b398f69a185882
https://doi.org/10.1007/s00345-014-1458-3
Zobrazit plný text záznamu
9
Tyrosine kinase inhibitor sorafenib decreases 111In-girentuximab uptake in patients with clear cell renal cell carcinoma
Autor: Peter F.A. Mulders, Marye J Boers-Sonderen, Egbert Oosterwijk, Mirjam de Weijert, Alexander B. Stillebroer, Carla M.L. van Herpen, Otto C. Boerman, Johan F. Langenhuijsen, Wim J.G. Oyen, William P.J. Leenders, Ingrid M.E. Desar, Constantijn H.J. Muselaers
Publikováno v: The Journal of Nuclear Medicine (1978), 55, 242-7
The Journal of Nuclear Medicine (1978), 55, 2, pp. 242-7
Item does not contain fulltext Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of metastatic clear cell renal cell carcinoma (RCC). Although TKIs have demonstrated good clinical efficacy, the lack of complete responses, the chroni
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6f1b659254d02e96ea6167aeb9572c3
https://hdl.handle.net/2066/137139
Zobrazit plný text záznamu
10
Neoadjuvant sorafenib treatment of clear cell renal cell carcinoma and release of circulating tumor fragments
Autor: Stijn Muselaers, J.C. Oosterwijk-Wakka, Cathy Maass, Peter F.A. Mulders, William P.J. Leenders, Ingrid M.E. Desar, Carla M.L. van Herpen, Robert M.W. de Waal, Han van Krieken, Christina A. Hulsbergen-van de Kaa, Mirjam de Weijert, Egbert Oosterwijk, Gursah Kats-Ugurlu
Publikováno v: Neoplasia: An International Journal for Oncology Research, Vol 16, Iss 3, Pp 221-228 (2014)
Neoplasia, 16, 3, pp. 221-8
Neoplasia, 16, 221-8
Contains fulltext : 136369.pdf (Publisher’s version ) (Open Access) BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is characterized by high constitutive vascular endothelial growth factor A (VEGF-A) production that induces a specific vascular
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c52cd59b15fedd784a4ed8f84e6531c
https://hdl.handle.net/2066/136369
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje